Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...

A new approach using RNA instead of DNA has improved the accuracy of liquid biopsy tests for early-stage colorectal cancer, according to a study by researchers at the University of Chicago. The method ...

While RNA sequencing (RNA-seq) has become a standard tool for profiling which genes are active in an organism, determining ...

A protein called LENG8 traps defective RNA molecules inside the cell nucleus before they can reach the cytoplasm and disrupt normal cellular function, according to a study published in Molecular Cell ...

Researchers at Hiroshima University have developed a new tool to quickly and accurately map fungal gene functions, even for ...

The Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected to attain a value of USD 29.6 Billion by 2035 at a CAGR of 9.55% during the forecast period 2025-2035. The RNA ...